Except for uromodulin, there was an increasing trend in biomarker concentrations with advancing CKD stages.
← all excerpts
Bridging conventional clinical tests and advanced biomarkers for the early diagnosis of kidney disease progression.
2
—
—
The sentences
Moreover, a decreasing trend of serum uromodulin can be seen in patients at different CKD stages.